Invention Grant
- Patent Title: MDMA treatment to enhance acute emotional effects profile of LSD, psilocybin, or other psychedelics
-
Application No.: US17238088Application Date: 2021-04-22
-
Publication No.: US11963946B2Publication Date: 2024-04-23
- Inventor: Matthias Emanuel Liechti
- Applicant: Universitätsspital Basel
- Applicant Address: CH Basel
- Assignee: Universitätsspital Basel
- Current Assignee: Universitätsspital Basel
- Current Assignee Address: CH Basel
- Agency: Kohn and Associates PLLC
- Main IPC: A61P25/22
- IPC: A61P25/22 ; A61K31/36 ; A61K31/48 ; A61P25/24

Abstract:
A method of enhancing positive effects of a psychedelic, by inducing a positive psychological state in an individual with an empathogen/entactogen, administering a psychedelic to the individual, and enhancing a positive response to the psychedelic. A composition including an entactogen/empathogen and a serotonergic psychedelic in the same dosage form or administered as separate compositions within a combination treatment schedule. A method of enhancing positive effects of a psychedelic, by inducing the release of endogenous monoamines, and subsequently stimulating 5-HT2A receptors.
Public/Granted literature
- US20210346341A1 MDMA TREATMENT TO ENHANCE ACUTE EMOTIONAL EFFECTS PROFILE OF LSD, PSILOCYBIN, OR OTHER PSYCHEDELICS Public/Granted day:2021-11-11
Information query